Golimumab

Results: 41



#Item
31Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2013-01-01 09:43:57
32Janssen Biotech Inc. Sharps Disposal Plan

Janssen Biotech Inc. Sharps Disposal Plan

Add to Reading List

Source URL: www.calrecycle.ca.gov

Language: English - Date: 2014-07-17 18:08:51
33HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® (golimumab) safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) Inje

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® (golimumab) safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) Inje

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-08-10 12:14:47
34HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® ARIATM safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab)

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® ARIATM safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-02-13 12:50:12
35September 20, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of

September 20, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of "Simponi®”, a human TNFα monoclonal antibody in Indonesia Osaka, Japan, September 20, [removed]Mitsubishi Tanabe Pharma Corporation (Pres

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-09-24 21:13:30
36Friday, February 1, 2013 from 6:30pm to 7:15pm [Attendees] Kenichi Yanagisawa, Board Director and Senior Managing Executive Officer, Division Manager of Sales & Marketing Division Kenkichi Kosakai, Board Director and Ma

Friday, February 1, 2013 from 6:30pm to 7:15pm [Attendees] Kenichi Yanagisawa, Board Director and Senior Managing Executive Officer, Division Manager of Sales & Marketing Division Kenkichi Kosakai, Board Director and Ma

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-02-08 00:41:53
37Imprimer Effacer DEMANDE D’AUTORISATION DE PAIEMENT Adalimumab (HumiraMC), étanercept (EnbrelMC), golimumab (SimponiMC)

Imprimer Effacer DEMANDE D’AUTORISATION DE PAIEMENT Adalimumab (HumiraMC), étanercept (EnbrelMC), golimumab (SimponiMC)

Add to Reading List

Source URL: www.ramq.gouv.qc.ca

Language: French - Date: 2014-07-21 11:01:36
    38HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for sub

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for sub

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2013-11-15 13:27:29
    39SPECIAL AUTHORIZATION REQUEST PSORIATIC ARTHRITIS Fax requests to[removed]OR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 HIGH-COST DRUG PATIENT APPLICATION ALSO REQUIRED PRIOR TO CO

    SPECIAL AUTHORIZATION REQUEST PSORIATIC ARTHRITIS Fax requests to[removed]OR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 HIGH-COST DRUG PATIENT APPLICATION ALSO REQUIRED PRIOR TO CO

    Add to Reading List

    Source URL: www.gov.pe.ca

    Language: English - Date: 2011-05-12 10:41:06
    40Simponi (golimumab) label

    Simponi (golimumab) label

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2012-03-15 14:14:14